Healthcare Economics & Policy

One of the nation’s largest faith-based health systems, Adventist Health System, will soon change its name to AdventHealth.
Alphabet, the parent company of Google, is investing $375 million into a healthcare startup called Oscar Health.
CVS Health’s takeover of health insurance giant is likely close to clearing the antitrust process with the Department of Justice, Bloomberg reported last week.
National health spending rose 5.2 percent to $3.66 trillion in June 2018 from the previous year, according to a new insights report from Alarum.
George Hahn of Philadelphia had two echocardiograms conducted at the same hospital a year apart, using the same insurance—the only difference was one cost $3,000 more than the other. Hahn’s plight is similar to many other Americans—and hospitals are acting, reports the Philadelphia Inquirer.
With immigration certainly a central issue in the 2018 mid-term elections, a new study could fuel debates about the dollars and cents of policy proposals. Researchers from Harvard Medical School and Tufts University found that immigrants’ healthcare costs were significantly lower than those of individuals born in the United States.
The American Medical Association (AMA) has urged the U.S. Department of Justice to block the planned $69 billion merger between CVS Health and Aetna.
Healthcare premiums have been rising rapidly over the past two years, but not all markets are seeing the same rates of inflation. Areas with fewer insurers are reporting higher premiums than other markets, according to a recent study published in Health Affairs.
Cigna executives are moving ahead with the planned acquisition of Express Scripts—despite objections by activist investor Carl Icahn.
Tenet Healthcare, a Dallas-based healthcare services company, is struggling to offload its business services subsidiary, Conifer Health Solutions.
Investor Carl Icahn penned a public letter to shareholders of health insurance company Cigna in an effort to derail the acquisition of Express Scripts, a pharmacy benefits manager, for more than $60 billion.
The CDC reported more than 50 percent of drug overdose deaths involve an opioid. And in the past two decades, opioid-related overdose deaths has increased by more than five times.
Healthcare was once again a leader among the number of jobs added to the economy in July, according to the most recent jobs report from the U.S. Bureau of Labor Statistics.
The planned merger of CVS Health and Aetna hit a snag this week after California Insurance Commissioner Dave Jones urged the U.S. Department of Justice to block the $69 billion deal.
More than 200 health services deals were reported in the second quarter of 2018, continuing the ongoing streak of mergers and acquisitions in the sector, according to PricewaterhouseCoopers.
Considering healthcare will be a central topic in the run up to the 2018 mid-term elections, “Medicare for all” is a concept that is gaining traction among left-leaning politicians. A recent study, though, found that implementation of such a program would cost $32.6 trillion over 10 years.
Healthcare Economics & Policy
Toledo, Ohio-based ProMedica announced its acquisition of Quality Care Properties and its principal tenants, HCR ManorCare and Arden Courts. The $4.4 billion transaction was possible thanks to a joint venture with Welltower, an in vestment first focused on healthcare-related real estate.
Healthcare Economics & Policy, Leadership
Alan Andrew Beauchamp, Dallas-based Forest Park Medical Center’s co-founder and former manager, pleaded guilty in a $200 million healthcare fraud case. Beauchamp recruited high-volume specialty doctors and paid them $40 million in bribes and kickbacks to perform surgeries.
Healthcare Economics & Policy
GlaxoSmithKline (GSK) announced a four-year, $300 million deal with 23andMe, a personal genomics and biotechnology company based in Mountain View, California. The British pharmaceutical company will have access to genetic information of 23andMe’s five million customers.
Healthcare Economics & Policy, Health IT
Eight years ago, Tom Price, MD, warned how “defensive medicine” drove healthcare costs, estimating 26 cents of every dollar went to unnecessary tests to protect physicians and hospitals from malpractice suits. The estimate wasn’t taken seriously back then, but researchers are now offering an estimate that 5 percent of costs can be attributed to such practices.
Healthcare Economics & Policy
A new report co-commissioned by Politico and the Harvard T.H. Chan School of Public Health, delved deeper into Americans’ outlook regarding the Trump administration’s policies to address prescription drug prices. Though President Donald Trump has called this one of his “greatest priorities,” poll numbers show the country is skeptical.
Healthcare Economics & Policy